.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Novartis
Argus Health
Teva
QuintilesIMS
Fish and Richardson
Cipla
Fuji
McKinsey

Generated: December 15, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to France Patent: 03 01849

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Forest Labs IncFETZIMAlevomilnacipran hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL204168-001Jul 25, 2013RXYesNo► Subscribe► Subscribe► SubscribeTREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
Forest Labs IncFETZIMAlevomilnacipran hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL204168-002Jul 25, 2013RXYesNo► Subscribe► Subscribe► SubscribeTREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
Forest Labs IncFETZIMAlevomilnacipran hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL204168-003Jul 25, 2013RXYesNo► Subscribe► Subscribe► SubscribeTREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
Forest Labs IncFETZIMAlevomilnacipran hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL204168-004Jul 25, 2013RXYesYes► Subscribe► Subscribe► SubscribeTREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist